CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,897,302 | -23.5% | 41,800 | -5.4% | 0.00% | -55.6% |
| Q2 2023 | $2,481,388 | +46.3% | 44,200 | +17.9% | 0.01% | -64.0% |
| Q1 2023 | $1,696,125 | -43.4% | 37,500 | -49.1% | 0.02% | -54.5% |
| Q4 2022 | $2,994,198 | +51.8% | 73,658 | +143.9% | 0.06% | +44.7% |
| Q3 2022 | $1,973,000 | +142.1% | 30,200 | +52.1% | 0.04% | -20.8% |
| Q3 2019 | $815,000 | +98.8% | 19,855 | +128.2% | 0.05% | +6.7% |
| Q2 2019 | $410,000 | +24.6% | 8,700 | -5.4% | 0.04% | -16.7% |
| Q1 2019 | $329,000 | – | 9,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |